ShockWave Medical Inc.

NASDAQ: SWAV · Real-Time Price · USD
334.75
-0.08 (-0.02%)
At close: May 30, 2024, 10:00 PM

ShockWave Medical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
147.28M 216M -9.14M
Depreciation & Amortization
10.36M 4.86M 5.54M
Stock-Based Compensation
73.23M 44.89M 27.26M
Other Working Capital
28.57M 3.15M 19.43M
Other Non-Cash Items
-5.72M 7.2M 511K
Deferred Income Tax
14.76M -97.28M 7.39M
Change in Working Capital
-43.86M -57.93M -16.52M
Operating Cash Flow
196.05M 117.73M 15.04M
Capital Expenditures
-30.59M -25.13M -12.44M
Cash Acquisitions
-94.41M 37.02M -26.42M
Purchase of Investments
-747.47M -137.8M -117.25M
Sales Maturities Of Investments
246.75M 100.77M 156.1M
Other Investing Acitivies
-500.72M -37.02M 26.42M
Investing Cash Flow
-625.73M -62.15M 26.42M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
-43K -23K -8.34M
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
600.4M 13M -2.45M
Financial Cash Flow
600.4M 13M -2.45M
Net Cash Flow
171.84M 67.43M 39M
Free Cash Flow
165.46M 92.61M 2.6M